Unexplained weight loss (UWL), defined as a loss of 5% or more of total body weight within a six to twelve month period without a clear etiology, often presents a diagnostic challenge for clinicians. This article aims to provide a comprehensive approach to diagnosing UWL, focusing on the importance of a thorough patient history, physical examination, and appropriate laboratory testing.
The first step in diagnosing UWL is a thorough patient history. Inquiring about changes in appetite, dietary habits, and physical activity levels can often provide clues to the underlying cause. Additionally, a detailed review of systems can reveal symptoms that suggest specific organ system involvement. Psychosocial history, including stressors and mood changes, can also be crucial, as depression can often manifest as UWL.
A comprehensive physical examination is also essential. The presence of lymphadenopathy, hepatosplenomegaly, or abnormal thyroid findings may suggest malignancy, infection, or endocrine disorders, respectively. Skin changes can indicate malabsorption or chronic liver disease, while neurological findings may point towards a neurodegenerative disorder.
Appropriate laboratory testing is the next step, guided by clues from the history and physical examination. Basic tests should include a complete blood count, metabolic panel, thyroid function tests, and urinalysis. Depending on the clinical suspicion, further tests may include imaging studies, endoscopy, or biopsy.
UWL is a complex clinical presentation that requires a methodical and comprehensive diagnostic approach. A detailed patient history, thorough physical examination, and appropriate laboratory testing are key to identifying the underlying cause. Further research is needed to develop more precise diagnostic algorithms and to understand the pathophysiology of UWL in patients with no identifiable cause.
1.
AI-based liquid biopsy shows promise for detecting brain cancer
2.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
3.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
4.
Ignoring Colonoscopy Advice; Dry Mouth Acupuncture; Inflamed Tongue, Then Cancer.
5.
Males with early-onset colorectal cancer are at risk, according to a study.
1.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
4.
Innovative Breakthroughs in Hematology for Modern Medicine
5.
Precision Erythropoietic Modeling for Hematologic Disorders
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Role of Screening in Cancer Prevention
2.
Innovations in Hematology
3.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
4.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation